Early snips & notes | Biotech Message Board Posts

Biotech   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  30067 of 30942  at  2/27/2020 6:19:31 AM  by


Early snips & notes


$GILD $80 up 8% on #coronavirus

Baird $VIR/Kumar: Pipeline Cannot Support Valuation; Downgrading to Underperform, $17 PT

$BCLI Announces 5th and final Site for Progressive Multiple Sclerosis Phase 2 Clinical Trial. Topline results in Q4 2020

$TDOC PT raised to $142 from $87 at Piper Sandler

$GSK EMA accepts submission of MAA for Zejula (niraparib) in first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer

$ABIO S-1 $15M offering+ warrants

$LLY FDA Advisory Committee Votes in Favor of CYRAMZA® (ramucirumab) as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer #NSCLC

$ESPR Announces FDA Approval of the NEXLIZET™ (bempedoic acid and ezetimibe) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine

Canaccord - $APTO | Revisiting APTO as CG-806 comes into focus; raising our PT to $13 from $7, reiterate BUY


Baml $SRPT key driver μdys gene therapy (SRP-9001), study 102 now has 30+ pts dosed from tx arm and cross-over. SRPT has now achieved commercially viable yields, highlighted key factors prior to trial's start: (1) site initiation/training, (2) assay work, (3) GMP runs.increase pipeline plug to $3bn (prev. $2bn) based on recent developments, incl. Stridebio collaboration. new $184 PO reiterate Buy as await LGMD data next qtr& PPMO data mid year. view the key de-risking factor for SRPT as start of study '301 (current guidance is mid-year 2020).

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 11     Views: 122
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Msg # Subject Author Recs Date Posted
30068 Re: Early snips & notes minxmrphd 5 2/27/2020 6:30:53 AM

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
Financial Market Data provided by